Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Alimera Sciences Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 39 | 52 | +13 |
| Shares | 47.9M | 46.4M | −1.54M (−3.2%) |
| Value | $186.9M | $257.9M | +$71.0M (+38.0%) |
New holders (27)
Institutions that held Alimera Sciences Inc at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (14)
Institutions that held Alimera Sciences Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Clearline Capital LP | 2,085,291 | $8.13M |
| AIGH Capital Management LLC | 1,520,359 | $5.93M |
| Ancora Advisors, LLC | 234,620 | $915.0K |
| Susquehanna International Group, LLP | 107,101 | $417.7K |
| Marshall Wace, LLP | 85,301 | $332.7K |
| Goldman Sachs Group Inc | 71,758 | $279.9K |
| Hillsdale Investment Management Inc. | 43,400 | $169.3K |
| Citadel Advisors LLC | 28,871 | $112.6K |
| Jefferies Financial Group Inc. | 26,100 | $101.8K |
| HRT Financial LP | 25,586 | $99.0K |
| Fifth Lane Capital, LP | 21,238 | $82.8K |
| Balyasny Asset Management LLC | 10,323 | $40.3K |
| Advisor Group Holdings, Inc. | 4,065 | $15.9K |
| Macquarie Group Ltd | 523 | $2 |